Test for FRα via IHC early to understand her treatment options at platinum resistance1,2

FRα=folate receptor alpha; IHC=immunohistochemistry.

FRα expression IHC SCORING ALGORITHM determines eligibility for ELAHERE, a targeted treatment USED IN PROC3,4

Chart showing the VENTANA FOLR1 assay scoring algorithm for EOC, including a positive staining example

A positive FOLR1 IHC result may make a patient with ovarian cancer a candidate for ELAHERE monotherapy once they become resistant to platinum-based chemotherapy.3,4

*Rereading by additional pathologists for FOLR1 scoring. To decrease variability of FOLR1 results for cases with %TCs near the threshold of 75% (65% to 85%), rereading of the slide by a second pathologist is recommended.3

EOC=epithelial ovarian cancer; FOLR1=folate receptor 1; FRα=folate receptor alpha; IHC=immunohistochemistry; PROC=platinum-resistant ovarian cancer; TC=tumor cell.

Results of FRα testing can impact treatment decisions3,4

Positive
Positive staining image

Exhibits 95% with 2+ and 3+ membrane staining or ≥75% with 2+ or 3+ membrane staining with complete circumferential pattern†

Positive staining image

Exhibits 85% with 2+ and 3+ apical membranous staining or 
≥75% of the tumor cells with 2+ and/or 3+ apical membrane
staining

Negative
Negative staining image

Exhibits 0% with 2+ and 3+ tumor cell membrane staining or <75% of tumor cells with 2+ and/or 3+ tumor cell membrane staining relative to the negative control slide

Negative staining image

Exhibits 20% with 2+ and 3+ membrane staining or <75% with 2+ and/or 3+ tumor cell membrane staining

Images shown for illustrative purposes only.

†Partial circumferential membrane staining patterns are also acceptable for FOLR1 positivity.

FOLR1 positivity does not require complete circumferential membrane staining.3

Refer to the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Interpretation Guide for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer to aid in clinical evaluation of stained samples, including photographic images that illustrate staining patterns.

Need more information
about FRα (FOLR1) testing?

A representative can answer additional questions
you may have about testing for FRα with FOLR1 IHC.

Take a look at 
the clinical data

Explore the results of ELAHERE vs 
standard chemotherapy.